Biosynthetic and Metabolic Alterations in Cancer Growth

ISSN: 2211-5536 (Online)
ISSN: 2211-5528 (Print)

Volume 4, 2 Issues, 2015

Download PDF Flyer

Current Angiogenesis (Discontinued)

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Guo-Chang Fan
Dept. of Pharmacology and Cell Biophysics
University of Cincinnati College of Medicine

View Full Editorial Board

Purchase Articles Order Reprints

Biosynthetic and Metabolic Alterations in Cancer Growth

Current Angiogenesis (Discontinued), 2(2): 149-156.

Author(s): Jie Zheng and Peng Gao.

Affiliation: Department of Pathology, School of Medicine, Southeast University, Nanjing 210009, People’s Republic of China.


Although cancers are derived from human body, their metabolic regulations are different from most normal tissues which mainly reflect on energy and biosynthesis metabolism. In energy metabolism, cancer cells take up glucose and glutamine at a high rate for aerobic glycolysis (Warburg effects). Although aerobic glycolysis does seem wasteful, it is essential for cancer growth in both energy supply and biosynthesis. In biosynthesis, nucleic acid, lipid and protein synthesis are more active in cancer cells than normal cells, but synthetic pathways in cancer cells are different from normal cells, cancer cells prefer to de novo synthesis even though it is not economic. Altered biosynthesis in cancer has challenges, but also opportunities. Understanding the process of cancer biosynthesis will help to develop new approaches in early diagnosis and target therapy of cancer.


Biosynthesis, cancer, lipid, mTOR, nucleic acid, protein.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 2
Issue Number: 2
First Page: 149
Last Page: 156
Page Count: 8
DOI: 10.2174/2211552802666140131104038
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science